Company profile: Cytokinetics
1.1 - Company Overview
Company description
- Provider of biopharmaceutical therapies under development for cardiovascular and neuromuscular diseases, including Omecamtiv Mecarbil, a cardiac myosin activator for heart failure with reduced ejection fraction; Aficamten (CK-274), a cardiac myosin inhibitor for hypertrophic cardiomyopathy; and CK-2127107, a fast skeletal muscle troponin activator. Conducts clinical trials to assess safety and efficacy.
Products and services
- Aficamten (CK-274): Clinical-stage cardiac myosin inhibitor under investigation for the treatment of hypertrophic cardiomyopathy, aiming to reduce heart muscle thickening in diagnosed patients
- CK-2127107: Investigational-stage fast skeletal muscle troponin activator designed to improve muscle function and exercise tolerance in conditions like heart failure, enhancing skeletal muscle performance
- Omecamtiv Mecarbil: Investigational-stage cardiac myosin activator being evaluated for potential to improve heart function in patients with heart failure with reduced ejection fraction
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cytokinetics
Millet Innovation
HQ: France
Website
- Description: Provider of medical and cosmetic personal care products, designing, manufacturing and marketing solutions distributed under the Epitact brand. Its Epitact Podologie line offers around 40 podiatry foot care products, including treatments for aches and pains, callus, corns and damaged nails.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millet Innovation company profile →
Radius Pharmaceuticals
HQ: United States
Website
- Description: Provider of drug therapies for osteoporosis and women's health, including TYMLOS (abaloparatide) for treatment of osteoporosis in postmenopausal women and men at high risk for fracture. Offers Radius Assist to provide TYMLOS at no cost to eligible patients, and supports investigator-initiated study grants and medical education grants to enhance understanding and patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Radius Pharmaceuticals company profile →
Intellirod Spine
HQ: United States
Website
- Description: Provider of spinal fusion assessment technologies, including wireless implantable microelectronic lumbar fusion sensors, disposable intraoperative rod strain sensors (LOADPRO) to measure strain and aid deformity correction, postoperative implantable sensors (ACCUVISTA) to monitor healing, a wearable iLink sensor to track recovery, and an RFID-enabled system to reduce CT scan reliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intellirod Spine company profile →
EOS Imaging
HQ: France
Website
- Description: Provider of low-dose, full-body musculoskeletal imaging solutions for orthopedic surgeons and radiologists, including the EOS 2D/3D imaging system and EOSedge with a high-resolution photon-counting detector; 3D Modeling to transform biplanar images into patient-specific 3D models for surgical planning; and the sterEOS workstation for analysis, 3D model generation, and clinical parameters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EOS Imaging company profile →
Synovis Life Technologies
HQ: United States
Website
- Description: Provider of implantable biomaterial medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synovis Life Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cytokinetics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cytokinetics
2.2 - Growth funds investing in similar companies to Cytokinetics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cytokinetics
4.2 - Public trading comparable groups for Cytokinetics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →